Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Central Catheters Tied to Dialysis-Related Infections

By HospiMedica International staff writers
Posted on 10 Jul 2017
Central venous catheter (CVC) use for hemodialysis is linked to an increased rate of bloodstream infections, according to a new study.

Researchers at the U.S. More...
Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA) conducted an analysis of data from 6,005 outpatient hemodialysis facilities across the United States who reported incidence rates of three types of dialysis events to the CDC National Healthcare Safety Network (NHSN) - bloodstream infection (BSI); intravenous antimicrobial start; and pus, redness, or increased swelling at the vascular access site. The data included events for hemodialysis outpatients treated at each facility during the first two working days of each month.

The hemodialysis facilities reported data on a total of 160,971 dialysis events, which included 29,516 BSIs; 149,722 intravenous antimicrobial starts; and 38,310 episodes of pus, redness, or increased swelling. The researchers then calculated event rates stratified by vascular access type--arteriovenous fistula (AVF), arteriovenous graft (AVG), or central venous catheter (CVC). They then standardized infection ratios by comparing each individual facility observed with predicted numbers of infections for bloodstream infections.

The results showed that 77% of BSIs were related to accessing the patients' circulation. A majority--63% of BSIs and 70% of access-related BSIs--occurred in patients that had a CVC. Other dialysis event rates were also highest among patients using CVCs. Staphylococcus aureus was the most commonly isolated BSI pathogen (31%) among those that suffered an infection, and 40% of S. aureus isolates tested were methicillin resistant. The study was published on June 29, 2017, in the Clinical Journal of the American Society of Nephrology (CJASN).

“We now have a clearer picture of the rates and types of infections hemodialysis patients in the United States are experiencing, as nearly all US outpatient hemodialysis facilities are participating in CDC's NHSN dialysis event surveillance,” said lead author Duc Bui Nguyen, MD, of the Division of Healthcare Quality Promotion. “Our findings emphasize the need for hemodialysis facilities to improve infection prevention and vascular access care practices.”

An AVF is the most recommended access for kidney patients who must undergo dialysis, created by connecting a patient's vein and artery to form a long-lasting site through which blood can be removed and returned. Alternatively, in patients who are unsuitable for a fistula, an AVG--a plastic conduit between an artery and a vein--may be used. Some patients, however, prefer a CVC, for reasons that include inadequate preparation for dialysis, avoidance of surgery, or fear of needles (since the connection to the dialysis machine via a catheter does not require needles).

Related Links:
U.S. Centers for Disease Control and Prevention


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.